Suppr超能文献

口服和注射用制剂中的增溶剂

Solubilizing excipients in oral and injectable formulations.

作者信息

Strickley Robert G

机构信息

Formulation & Process Development, Gilead Sciences Inc., Foster City, California 94404, USA.

出版信息

Pharm Res. 2004 Feb;21(2):201-30. doi: 10.1023/b:pham.0000016235.32639.23.

Abstract

A review of commercially available oral and injectable solution formulations reveals that the solubilizing excipients include water-soluble organic solvents (polyethylene glycol 300, polyethylene glycol 400, ethanol, propylene glycol, glycerin, N-methyl-2-pyrrolidone, dimethylacetamide, and dimethylsulfoxide), non-ionic surfactants (Cremophor EL, Cremophor RH 40, Cremophor RH 60, d-alpha-tocopherol polyethylene glycol 1000 succinate, polysorbate 20, polysorbate 80, Solutol HS 15, sorbitan monooleate, poloxamer 407, Labrafil M-1944CS, Labrafil M-2125CS, Labrasol, Gellucire 44/14, Softigen 767, and mono- and di-fatty acid esters of PEG 300, 400, or 1750), water-insoluble lipids (castor oil, corn oil, cottonseed oil, olive oil, peanut oil, peppermint oil, safflower oil, sesame oil, soybean oil, hydrogenated vegetable oils, hydrogenated soybean oil, and medium-chain triglycerides of coconut oil and palm seed oil), organic liquids/semi-solids (beeswax, d-alpha-tocopherol, oleic acid, medium-chain mono- and diglycerides), various cyclodextrins (alpha-cyclodextrin, beta-cyclodextrin, hydroxypropyl-beta-cyclodextrin, and sulfobutylether-beta-cyclodextrin), and phospholipids (hydrogenated soy phosphatidylcholine, distearoylphosphatidylglycerol, L-alpha-dimyristoylphosphatidylcholine, L-alpha-dimyristoylphosphatidylglycerol). The chemical techniques to solubilize water-insoluble drugs for oral and injection administration include pH adjustment, cosolvents, complexation, microemulsions, self-emulsifying drug delivery systems, micelles, liposomes, and emulsions.

摘要

对市售口服和注射用溶液制剂的综述表明,增溶辅料包括水溶性有机溶剂(聚乙二醇300、聚乙二醇400、乙醇、丙二醇、甘油、N-甲基-2-吡咯烷酮、二甲基乙酰胺和二甲基亚砜)、非离子表面活性剂(聚氧乙烯蓖麻油EL、聚氧乙烯蓖麻油RH 40、聚氧乙烯蓖麻油RH 60、维生素E聚乙二醇1000琥珀酸酯、聚山梨酯20、聚山梨酯80、Solutol HS 15、脱水山梨醇单油酸酯、泊洛沙姆407、Labrafil M-1944CS、Labrafil M-2125CS、Labrasol、Gellucire 44/14、Softigen 767以及PEG 300、400或1750的单脂肪酸酯和二脂肪酸酯)、水不溶性脂质(蓖麻油、玉米油、棉籽油、橄榄油、花生油、薄荷油、红花油、芝麻油、大豆油、氢化植物油、氢化大豆油以及椰子油和棕榈籽油的中链甘油三酯)、有机液体/半固体(蜂蜡、维生素E、油酸、中链单甘油酯和二甘油酯)、各种环糊精(α-环糊精、β-环糊精、羟丙基-β-环糊精和磺丁基醚-β-环糊精)以及磷脂(氢化大豆卵磷脂、二硬脂酰磷脂酰甘油、L-α-二肉豆蔻酰磷脂酰胆碱、L-α-二肉豆蔻酰磷脂酰甘油)。用于口服和注射给药的水不溶性药物增溶化学技术包括pH调节、助溶剂、络合、微乳、自乳化给药系统、胶束、脂质体和乳剂。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验